{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:10:48Z","timestamp":1762668648437,"version":"build-2065373602"},"reference-count":0,"publisher":"Indian Orthopaedic Research Group","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jocr"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Introduction: Total hip arthroplasty (THA) carries a persistent risk of venous thromboembolism (VTE). Contemporary guidelines endorse combined mechanical and pharmacologic prophylaxis often extended to 35 days post-operative; yet the optimal agent remains debated as evidence comparing aspirin with low-molecular-weight heparin (LMWH) is mixed (e.g., EPCAT II vs. CRISTAL).\n\nMaterials and Methods: We conducted a retrospective, propensity-matched cohort study using the TriNetX Network. Adults undergoing primary THA were assigned to mutually exclusive cohorts based on initial post-operative chemoprophylaxis within 7 days: Aspirin (no LMWH exposure in days 0\u20137) or LMWH (no aspirin exposure in days 0\u20137). Outcomes were assessed from post-operative day 1 to day 365. One-to-one propensity score matching balanced age, sex, race\/ethnicity, body mass index, hypertension, ischemic heart disease, heart failure, diabetes, obesity, and metabolic disorders. Effect measures included risk difference (RD) with two-sided P (primary; also applied to risk ratio [RR] per protocol), (RR, 95% confidence interval [CI]), and hazard ratio (HR) from Kaplan\u2013Meier analysis with log-rank P. Statistical significance was set at P &lt; 0.05. Guideline context is provided for interpretability.\n\nResults: After matching (aspirin n = 8,559; LMWH n = 8,559), 1-year outcomes favored aspirin for thromboembolism. Any VTE: 1.7% versus 2.6%; RR = 0.649 (0.525\u20130.803), P &lt; 0.001; and HR = 0.635, P = 0.475. Deep vein thrombosis: 1.4% versus 2.3%; RR = 0.610 (0.485\u20130.769), P &lt; 0.001; and HR = 0.598, P = 0.142. Pulmonary embolism (PE): 0.6% versus 1.0%; RR = 0.665 (0.472\u20130.935), P = 0.018; and HR = 0.651, P = 0.603. Major bleeding: 11.1% versus 10.2%; RR = 1.089 (0.999\u20131.188), P = 0.053; and HR = 1.094, P = 0.001. Minor bleeding: 2.2% versus 2.1%; RR = 1.050 (0.858\u20131.284), P = 0.637; and HR = 1.029, P = 0.969. Emergency department visit: 13.6% versus 18.7%; RR = 0.727 (0.679\u20130.780), P &lt; 0.001; and HR = 0.694, P = 0.463. Findings align with guidance permitting aspirin as prophylaxis in appropriately selected arthroplasty patients, while acknowledging randomized evidence favoring LMWH in some settings.\n\nConclusions: In matched THA patients, aspirin achieved lower 1-year VTE than LMWH with no statistically significant increase in major bleeding by RD. Given trial heterogeneity (e.g., CRISTAL versus meta-analyses and step-down strategies), agent selection should be individualized, balancing thrombotic and bleeding risks, logistics, and patient preference within guideline-concordant, extended prophylaxis pathways (Two-sided significance threshold: P &lt; 0.05).\n\nKeywords: Lmwh, THA, Aspirin, VTE, Bleeding Risk<\/jats:p>","DOI":"10.13107\/jocr.2025.v15.i11.6388","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:06:46Z","timestamp":1762668406000},"page":"301-308","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Effectiveness of Aspirin and Low-molecular-weight heparin for Venous Thromboembolism Prophylaxis after Total Hip Arthroplasty"],"prefix":"10.13107","volume":"15","author":[{"name":"Department of Trauma and Orthopedic Surgery, Tameside and Glossop Integrated Care NHS Trust, Greater Manchester, United Kingdom,","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haji Bahar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Third Year MBBS, Punjab Medical College, Faisalabad Medical University, Faisalabad, Pakistan,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Nikose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Trauma and Orthopedic Surgery, Tameside and Glossop Integrated Care NHS Trust, Greater Manchester, United Kingdom,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syes Amir Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Trauma and Orthoipedic Surgery, Almana General Hospital, Kingdom of Saudi Arabia,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Miraj","family":"Shami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Trauma and Orthopeadics Surgey, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiqqas","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Trauma and Orthopedic Surgery, Tameside and Glossop Integrated Care NHS Trust, Greater Manchester, United Kingdom,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5271","published-online":{"date-parts":[[2025]]},"container-title":["Journal of Orthopaedic Case Reports"],"original-title":[],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:06:47Z","timestamp":1762668407000},"score":1,"resource":{"primary":{"URL":"https:\/\/jocr.co.in\/wp\/2025\/11\/comparative-effectiveness-of-aspirin-and-low-molecular-weight-heparin-for-venous-thromboembolism-prophylaxis-after-total-hip-arthroplasty\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":0,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.13107\/jocr.2025.v15.i11.6388","relation":{},"ISSN":["2321-3817"],"issn-type":[{"value":"2321-3817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}